Form 4: Tenax Therapeutics Insider Buys Shares

Sentiment:

Insider Transaction (Form 4)


ADAR1 Capital Management, LLC and 1 other reported changes in beneficial ownership of Tenax Therapeutics, Inc. common stock on August 20, 2026.

Summary

  • Open-market purchase: acquired 202,124 Common Stock at $1.78 ($359,538) on August 20, 2026; holds 4,030,075 after (Indirect).
  • Open-market purchase: acquired 716,369 Common Stock at $1.77 ($1,266,254) on August 21, 2026; holds 4,746,444 after (Indirect).
  • Open-market purchase: acquired 107,374 Common Stock at $1.75 ($188,355) on August 24, 2026; holds 4,853,818 after (Indirect).

Sentiment

Score: 9

Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $1,814,147, committing personal capital to the stock.

Insider Transactions

ADAR1 Capital Management, LLC — 10% owner

Daniel Schneeberger — 10% owner

DateTransactionSecuritySharesPriceValueHeld After
2026-08-20Open-market purchaseCommon Stock202,124$2$359.5K4,030,075
2026-08-21Open-market purchaseCommon Stock716,369$2$1.3M4,746,444
2026-08-24Open-market purchaseCommon Stock107,374$2$188.4K4,853,818

Key Dates

DateDescription
2026-08-20Open-market purchase (202,124 shares)
2026-08-21Open-market purchase (716,369 shares)
2026-08-24Open-market purchase (107,374 shares)

Keywords

insider transaction, Form 4, TENX, TENAX THERAPEUTICS, INC., bullish, ADAR1 Capital Management, LLC, Daniel Schneeberger

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.